Intas Pharmaceuticals Ltd — Ras Exporter Profile
Indian Pharmaceutical Exporter · #11 for Ras · $2.5M export value · DGFT Verified
Intas Pharmaceuticals Ltd is the #11 Indian exporter of Ras with $2.5M in export value and 51 verified shipments. Intas Pharmaceuticals Ltd holds a 0.8% market share in Ras exports across 8 countries.
Intas Pharmaceuticals Ltd — Ras Export Profile: Buyers & Destinations
Where Does Intas Pharmaceuticals Ltd Export Ras?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $12.1M | 313 | 56.8% |
| CANADA | $3.7M | 82 | 17.3% |
| PERU | $2.1M | 47 | 10.0% |
| UNITED STATES | $930.1K | 50 | 4.4% |
| LEBANON | $360.6K | 9 | 1.7% |
| NETHERLANDS | $251.9K | 14 | 1.2% |
| TANZANIA | $246.4K | 9 | 1.2% |
| SOUTH AFRICA | $244.0K | 8 | 1.1% |
| MEXICO | $189.9K | 12 | 0.9% |
| MALAYSIA | $169.3K | 9 | 0.8% |
Intas Pharmaceuticals Ltd exports Ras to 42 countries. The largest destination is UNITED KINGDOM accounting for 56.8% of Intas Pharmaceuticals Ltd's Ras shipments, followed by CANADA (17.3%) and PERU (10.0%). These destinations reflect Intas Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ras from Intas Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| FAWDON MANUFACTURING CENTRE ( SF ) | UNITED KINGDOM | $4.1M | 96 |
| FAWDON MAUFACTURING CENTRE (SF) | UNITED KINGDOM | $3.1M | 82 |
| APOTEX - CANADA | CANADA | $2.4M | 47 |
| FAWDON MANUFACTURING CENTRE (SF) | UNITED KINGDOM | $1.9M | 49 |
| FAWDON MANUFACTURING CENTRE SF | UNITED KINGDOM | $1.3M | 26 |
| ACCORD HEALTHCARE S.A.C. | PERU | $1.1M | 26 |
| APOTEX CANADA | CANADA | $1.0M | 20 |
| EVERSANA LIFE SCIENCES SERVICES,LLC | UNITED STATES | $929.8K | 30 |
| TO THE ORDER | POLAND | $873.8K | 46 |
| ACCORD HEALTHCARE S A C | PERU | $850.0K | 17 |
Intas Pharmaceuticals Ltd supplies Ras to 93 buyers globally. The largest buyer is FAWDON MANUFACTURING CENTRE ( SF ) (UNITED KINGDOM), followed by FAWDON MAUFACTURING CENTRE (SF) (UNITED KINGDOM) and APOTEX - CANADA (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ras Export Value and How Much Does Intas Pharmaceuticals Ltd Contribute?
India exported $123.4M worth of Ras through 15,000 shipments from 1156 suppliers to 176 countries, serving 2,323 buyers globally. Intas Pharmaceuticals Ltd contributes $2.5M to this total, accounting for 0.8% of India's Ras exports. Intas Pharmaceuticals Ltd ships Ras to 42 countries through 93 buyers.
What Is the Average Shipment Value for Intas Pharmaceuticals Ltd's Ras Exports?
Intas Pharmaceuticals Ltd's average Ras shipment value is $50.0K per consignment, based on 51 shipments totaling $2.5M. The largest destination is UNITED KINGDOM (56.8% of Intas Pharmaceuticals Ltd's Ras exports).
How Does Intas Pharmaceuticals Ltd Compare to Other Indian Ras Exporters?
Intas Pharmaceuticals Ltd ranks #11 among 1156 Indian Ras exporters with a 0.8% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($36.5M), MSN LABORATORIES PRIVATE LIMITED ($22.3M), MYLAN LABORATORIES LIMITED ($20.1M). Intas Pharmaceuticals Ltd processed 51 shipments to 8 destination countries.
What Ras Formulations Does Intas Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMA DRUGS & MEDI FILGRASTIM 300MCG/0.5ML PFS NUDE-EU TUB AS PER INVOICEVLS | $1.5M | 36 |
| PHARMACEUTICAL DRUGS AND MEDICINE-GRASTO | $1.1M | 22 |
| PHARMA DRUGS & MEDI: FILGRASTIM 480mcg/0 | $709.6K | 33 |
| PHARMA DRUGS & MEDI: FILGRASTIM 300mcg/0 | $683.6K | 46 |
| PHARMACEUTICAL DRUGS AND MEDICINE FILGRASTIM 300MCG/0.5ML PFS NUDE-EU TUB FILGRASTIM 300MCG/0.5ML PFS NUDE-EU TUB | $600.0K | 12 |
| PHARMA DRUGS & MEDI FILGRASTIM 300mcg/0. | $550.6K | 12 |
| PHARMA DRUGS & MEDI: PEGFILGRASTIM 6mg/0 | $538.0K | 18 |
| PHARMA DRUGS & MEDI FILGRASTIM 300MCG/0.5ML PFS NUDE-EU TUB AS PER INVOICE | $537.0K | 11 |
| PH.DRU.& MED.: NEUGRAST INJECTION (FILGRASTIM INJECTION 300MCG/ML) [1X1 PFS] | $520.1K | 11 |
| PHARMA DRUGS & MEDI: PEG FILGRASTIM 6mg/ | $495.2K | 19 |
Intas Pharmaceuticals Ltd exports 613 distinct Ras formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI FILGRASTIM 300MCG/0.5ML PFS NUDE-EU TUB with 36 shipments worth $1.5M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Ras to Key Markets
What Intas Pharmaceuticals Ltd must comply with to export Ras to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Intas Pharmaceuticals Ltd Compare to Nearest Ras Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | BIOCON BIOLOGICS INDIA LIMITED | $3.2M | 64 | 17 | $50.0K |
| 12 | MACLEODS PHARMACEUTICALS LTD | $3.2M | 64 | 9 | $50.0K |
| 11 | INTAS PHARMACEUTICALS LTD ★ | $2.5M | 51 | 8 | $50.0K |
| 14 | DR REDDYS LABORATORIES LIMITED | $2.1M | 43 | 8 | $50.0K |
| 9 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $2.1M | 42 | 6 | $50.0K |
Intas Pharmaceuticals Ltd ranks #11 among 1156 Indian Ras exporters. Average shipment value of $50.0K compared to the market average of $106.8K. The closest competitors by value are BIOCON BIOLOGICS INDIA LIMITED and MACLEODS PHARMACEUTICALS LTD.
Which Indian Ports Ship Ras Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,417 | 9.4% |
| DELHI AIR CARGO ACC (INDEL4) | 1,335 | 8.9% |
| NHAVA SHEVA SEA (INNSA1) | 947 | 6.3% |
| SAHAR AIR | 935 | 6.2% |
| DELHI AIR | 709 | 4.7% |
| Bombay Air | 648 | 4.3% |
| AHEMDABAD AIR ACC (INAMD4) | 528 | 3.5% |
| TUTICORIN SEA (INTUT1) | 406 | 2.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ras — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ras shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Intas Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 1,194 individual customs records matching Intas Pharmaceuticals Ltd exporting Ras, covering 613 formulations to 42 countries via 93 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 176+ countries, 2,323+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ras Export Data from Intas Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Intas Pharmaceuticals Ltd's Ras exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Intas Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Ras Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Intas Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ras. For current shipment-level data, contact TransData Nexus.